[Federal Register: February 9, 2006 (Volume 71, Number 27)]
[Page 6777]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Advisory Committee on Special Studies Relating to the Possible 
Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch 
Hand Advisory Committee); Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

    Name of Committee: Advisory Committee on Special Studies 
Relating to the Possible Long-Term Health Effects of Phenoxy 
Herbicides and Contaminants (Ranch Hand Advisory Committee).
    General Function of the Committee: To advise the Secretary of 
Health and Human Services (the Secretary) and the Assistant 
Secretary for Health concerning its oversight of the conduct of the 
Ranch Hand study by the U.S. Air Force and provide scientific 
oversight of the Department of Veterans Affairs Army Chemical Corps 
Vietnam Veterans Health Study, and other studies in which the 
Secretary or the Assistant Secretary for Health believes involvement 
by the committee is desirable.
    Date and Time: The meeting will be held on February 27, 2006, 
from 8:30 a.m. to 4 p.m.
    Location: Food and Drug Administration, 5630 Fishers Lane, rm. 
1066, Rockville, MD.
    Contact Person: Leonard Schechtman, National Center for 
Toxicological Research (HFT-10), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6696, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512560. Please call the Information 
Line for up-to-date information on this meeting.
    Agenda: The committee will discuss the following items: (1) 
Update on the Institute of Medicine's Air Force Health Study 
Disposition Study and related closure activities; (2) updates from 
the Air Force on the Viability Study, Compliance Study, 
Comprehensive Study, Mortality Update, Technical Reports, and 
External Collaborations.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by February 
17, 2006. Oral presentations from the public will be scheduled on 
February 27, 2006, between approximately 11:30 a.m. and 12:30 p.m. 
Time allotted for each presentation may be limited. Those desiring 
to make formal oral presentations should notify the contact person 
before February 17, 2006, and submit a brief statement of the 
general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication 
of the approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to 
electrical outlets.
    FDA welcomes the attendance of the public at its advisory 
committee meetings and will make every effort to accommodate persons 
with physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard 
Schechtman at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 2, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-1737 Filed2-8-06; 8:45 am]